ObjectiveThe objective of this research is to scrutinize adverse events (AEs) linked to Trifluridine/Tipiracil (TFTD/TPI). using data from the FDA Adverse Event Reporting System (FAERS) database. MethodsThe AEs data related to TFTD/TPI were collected from the fourth quarter of 2015 through the fourth quarter of 2023. After normalizing the data. https://danddcollectiblers.shop/product-category/serum/